Quest Diagnostics: Strong2Q Sees Organic Growth Accelerate; FY26 EPS Guidance Raised $0.42at Midpoint-20260723
奎斯特诊疗(US:DGX) 摩根大通·2026-07-23 22:26J P M O R G A N North America Equity Research 23 July 2026 Quest Diagnostics Strong 2Q Sees Organic Growth Accelerate; FY26 EPS Guidance Raised $0.42 at Midpoint DGX, DGX US Price (22 Jul 26):$209.83 Managed Care and Facilities Lisa C. Gill AC (1-212) 622-6466 lisa.c.gill@jpmorgan.com Cole Harris (1-212) 622-9068 cole.harris@jpmorgan.com John Stansel, CFA (1-212) 622-0083 john.stansel@jpmorgan.com Benjamin Rossi (1-212) 622-9603 benjamin.rossi@jpmorgan.com Quest Diagnostics (DGX) reported solid 2Q26 results ...